ATMRD 2025: Full Schedule

Pharmacological treatment of Parkinson’s disease has evolved over time from the first landmark trials of L-dopa through today’s newer formulations and adjunctive medications. This session describes the landmark medication trials that every clinician should know and the major lessons drawn from each, with a focus on the evolution that has led to improved control of parkinsonian symptoms.

CME Faculty

Stuart H. Isaacson, MD, FAAN

Director, Parkinson’s Disease and Movement Disorders Center of Boca Raton

Stuart H. Isaacson, MD, FAAN is the Director of the Parkinson’s Disease and Movement Disorders Center of Boca Raton in Florida, USA. Dr. Isaacson received his medical degree from Northwestern University School of Medicine in Chicago, Illinois. He completed fellowships at the National... Read More →

Friday June 27, 2025 9:30am - 10:00am EDT
Woodrow Wilson B-D

CME General

10:00am EDT

Integrating Adjunctive Medications to Customize Parkinson’s Care – 0.5 CME

Friday June 27, 2025 10:00am - 10:30am EDT

Woodrow Wilson B-D

Although L-dopa/carbidopa is the mainstay of treatment for Parkinson’s disease, its benefits begin to fluctuate over time. This session considers the available adjunctive medications that can be integrated into the treatment regimen to help manage the fluctuations and customize care as Parkinson’s progresses. Studies evaluating promising medications in development will also be described.

CME Faculty

Stuart H. Isaacson, MD, FAAN

Director, Parkinson’s Disease and Movement Disorders Center of Boca Raton

Friday June 27, 2025 10:00am - 10:30am EDT
Woodrow Wilson B-D

CME General

10:30am EDT

Conquering Off Episodes with On-Demand Therapies – 0.5 CME

Friday June 27, 2025 10:30am - 11:00am EDT

Woodrow Wilson B-D

The effects of L-dopa/carbidopa begin to fluctuate over time in people with Parkinson’s disease, leading to so-called OFF episodes that interfere with quality of life. This session discusses the on-demand therapies that can help provide relief for OFF episodes and how/when to use them. Emphasis is placed on results of clinical trials that document timing and optimal use of these medications.

CME Faculty

Cheryl Kyinn, PA-C

Certified Physician Assistant, Movement Disorder Parkinson's Disease Specialists

Non-CME Speaker for Amneal Pharmaceuticals

Friday June 27, 2025 10:30am - 11:00am EDT
Woodrow Wilson B-D

CME General

11:00am EDT

Non-Motor Therapies: More Than Modulating Dopamine – 0.5 CME

Friday June 27, 2025 11:00am - 11:30am EDT

Woodrow Wilson B-D

Nearly all people with Parkinson’s experience non-motor symptoms prior to motor manifestations, and additional non-motor features typically develop as the disease progresses. Non-motor symptoms can be among the most bothersome for patients and are critical to address. This session focuses on common non-motor symptoms, describing their timing in the disease course and pharmacological treatment.

CME Faculty

Fernando Pagan, MD

ATMRD Course Director, MedStar Georgetown University Hospital

Fernando L. Pagan, MD is a board-certified neurologist and Professor and Vice Chairman for the Department of Neurology at MedStar Georgetown University Hospital in Washington DC. He is the Director of the Movement Disorders Program and the Medical Director of MedStar Georgetown's... Read More →

Friday June 27, 2025 11:00am - 11:30am EDT
Woodrow Wilson B-D

CME General

12:30pm EDT

Lunch Industry Innovation Theater – Non-CME Event Sponsored by Amneal

Friday June 27, 2025 12:30pm - 1:45pm EDT

Woodrow Wilson B-D

Friday June 27, 2025 12:30pm - 1:45pm EDT
Woodrow Wilson B-D

Sponsored (Non-CME), Non-CME

4:30pm EDT

Using Advanced Therapies to Treat Challenging Cases in Parkinson's disease

Friday June 27, 2025 4:30pm - 5:45pm EDT

Woodrow Wilson B-D

Not all patients with Parkinson’s disease fit the textbook description. Fortunately, many of these patients benefit from the right combination of medications. In this panel discussion, experts consider challenging cases of Parkinson’s disease to help clinicians identify when and how to use different levodopa-based formulations and adjunctive therapies.

CME Faculty

Rajesh Pahwa, MD

Director of Parkinson Foundation Center of Excellence at the University of Kansas Medical Center., University of Kansas Medical Center

Rajesh Pahwa, M.D., is the Laverne and Joyce Rider Professor of Neurology, chief of the Parkinson's and Movement Disorder Division and director of Parkinson Foundation Center of Excellence at the University of Kansas Medical Center.Dr. Pahwa received his medical degree at Seth G.S... Read More →

Stuart H. Isaacson, MD, FAAN

Director, Parkinson’s Disease and Movement Disorders Center of Boca Raton

Cheryl Kyinn, PA-C

Certified Physician Assistant, Movement Disorder Parkinson's Disease Specialists

Non-CME Speaker for Amneal Pharmaceuticals

Friday June 27, 2025 4:30pm - 5:45pm EDT
Woodrow Wilson B-D

CME General

6:00pm EDT

Opening Ceremony

Friday June 27, 2025 6:00pm - 6:30pm EDT

Woodrow Wilson B-D

Friday June 27, 2025 6:00pm - 6:30pm EDT
Woodrow Wilson B-D

Connect & Recharge

8:00am EDT

Breakfast Industry Innovation Theater – Non-CME Event Sponsored by Acadia Pharmaceuticals Inc.

Saturday June 28, 2025 8:00am - 9:00am EDT

Woodrow Wilson B-D

Saturday June 28, 2025 8:00am - 9:00am EDT
Woodrow Wilson B-D

Sponsored (Non-CME), Non-CME

9:30am EDT

The Changing Landscape in DBS for Movement Disorders - 0.5 CME

Saturday June 28, 2025 9:30am - 10:00am EDT

Woodrow Wilson B-D

Technological advances are substantially altering the landscape for DBS treatment. This session explains key advances that characterize the field today, incorporating essential information for clinicians who use DBS or recommend it for their patients. Topics include remote programming, adaptive DBS, directional leads, closed-loop systems, rechargeable devices, and integration of existing systems with digital health tools.

CME Faculty

Anvi Gadani, MD

Medstar Georgetown University Hospital

Dr. Anvi Gadani is a Neurologist subspecializing in Movement Disorders with special interest in Memory Disorders at MedStar Montgomery Medical Center, affiliated with MedStar Georgetown University. She completed her residency in Neurology at the University of Connecticut and completed... Read More →

Gary Volkell, DO

MedStar Georgetown University Hospital

Gary Volkell, DO, is a board-certified neurologist who is fellowship trained in movement disorders. He sees patients at MedStar Franklin Square Medical Center.Dr. Volkell specializes in treatment for Parkinson’s disease, dystonia (including cervical dystonia/spasmodic torticollis... Read More →

Saturday June 28, 2025 9:30am - 10:00am EDT
Woodrow Wilson B-D

CME General

10:00am EDT

Advances in DBS Placement – 0.5 CME

Saturday June 28, 2025 10:00am - 10:30am EDT

Woodrow Wilson B-D

Advances in DBS placement can lead to improved outcomes and safety for patients. This session discusses innovations in imaging, robotic-assisted surgery, and real-time monitoring that enable more precise DBS placement and permit tailoring to individual patient anatomy and symptoms. The promise of asleep DBS will also be considered.

CME Faculty

Christopher Kalhorn, MD

MedStar Georgetown University Hospital

Dr. Christopher Kalhorn is Professor of Neurosurgery at Medstar Georgetown University Hospital. He is the Director of Functional and Epilepsy surgery at Medstar Georgetown. Dr. Kalhorn also serves as member of the Board of Directors at Medstar Health and is the Chair of the Quality... Read More →

Saturday June 28, 2025 10:00am - 10:30am EDT
Woodrow Wilson B-D

CME General

10:30am EDT

Reimagining Ablation in Movement Disorders: Magnetic Resonance Focused Ultrasound (MRfUS) – 0.5 CME

Saturday June 28, 2025 10:30am - 11:00am EDT

Woodrow Wilson B-D

MRfUS is emerging as an important treatment option for selected movement disorders. This session will describe the clinical applications and patient selection for MRfUS, as well as a procedural overview, potential mechanisms, safety considerations, and future directions.

CME Faculty

Justin Martello, MD

ChristianaCare

Dr. Martello earned his medical degree from the University of Maryland, Baltimore. He completed his neurology residency as well as his fellowship in movement disorders at University of Maryland Medical Center. This was after earning his bachelor’s degree with honors in biology from... Read More →

Saturday June 28, 2025 10:30am - 11:00am EDT
Woodrow Wilson B-D

CME General

11:15am EDT

Hope on the Horizon: Emerging Therapies in PD – 0.75 CME

Saturday June 28, 2025 11:15am - 12:00pm EDT

Woodrow Wilson B-D

Many new therapies are in development for Parkinson’s disease, from those grounded in the disease’s neuropathology to those repurposed from other indications. This session summarizes the status and evidence related to gene therapies, antibody-based therapies, growth factors, repurposed pharmacotherapies, and new formulations of existing medications.

CME Faculty

Rajesh Pahwa, MD

Director of Parkinson Foundation Center of Excellence at the University of Kansas Medical Center., University of Kansas Medical Center

Saturday June 28, 2025 11:15am - 12:00pm EDT
Woodrow Wilson B-D

CME General

12:30pm EDT

Lunch Industry Innovation Theater – Non-CME Event Sponsored by Supernus Pharmaceuticals

Saturday June 28, 2025 12:30pm - 1:30pm EDT

Woodrow Wilson B-D

Saturday June 28, 2025 12:30pm - 1:30pm EDT
Woodrow Wilson B-D

Sponsored (Non-CME), Non-CME

3:00pm EDT

Determining the Right Candidate for the Right Therapy – 1 CME

Saturday June 28, 2025 3:00pm - 4:00pm EDT

Woodrow Wilson B-D

Advanced therapy procedures such as DBS and MRfUS are important tools for treating selected movement disorders but it can be difficult to determine which patients are good candidates. With refinements in these procedures, the definition of a “good candidate” has evolved. This session uses case-based examples to identify patients who may benefit from advanced procedural therapies and how to select among the available treatment options.

CME Faculty

Pam Zeilman, NP

University of Florida Normal Fixel Institute for Neurological Disorders

Pam Zeilman is an Adult Nurse Practitioner who obtained her Master’s of Science in Adult Health Nursing at the University of Florida in 2006. She has been credentialed with the American Nurses Credentialing Center since 2007. Pam joined the University of Florida Normal Fixel Institute... Read More →

Rajesh Pahwa, MD

Director of Parkinson Foundation Center of Excellence at the University of Kansas Medical Center., University of Kansas Medical Center

Saturday June 28, 2025 3:00pm - 4:00pm EDT
Woodrow Wilson B-D

CME General

8:00am EDT

Breakfast Industry Innovation Theater – Non-CME Event Sponsored by Neurocrine Biosciences Inc.

Sunday June 29, 2025 8:00am - 9:00am EDT

Woodrow Wilson B-D

Sunday June 29, 2025 8:00am - 9:00am EDT
Woodrow Wilson B-D

Sponsored (Non-CME), Non-CME

9:30am EDT

Reining in the Movement With Huntington’s Chorea and Tardive Dyskinesia – 0.5 CME

Sunday June 29, 2025 9:30am - 10:00am EDT

Woodrow Wilson B-D

Hyperkinetic disorders can be difficult to diagnose, but correct identification is critical given the development of new treatments. This session focuses on Huntington’s chorea and tardive dyskinesia, two hyperkinetic disorders for which treatments are available. The session will cover the medications used to treat these disorders, including their mechanisms, efficacy, safety, and quality of life data based on clinical trials.

Sunday June 29, 2025 9:30am - 10:00am EDT
Woodrow Wilson B-D

CME General

10:00am EDT

When the Shoe Doesn’t Fit: Atypical Parkinsonisms – 0.5 CME

Sunday June 29, 2025 10:00am - 10:30am EDT

Woodrow Wilson B-D

Although atypical parkinsonisms share features with Parkinson’s disease, they have distinct disease courses and symptom profiles and require tailored clinical approaches. This session considers the differential diagnosis and treatment of multiple system atrophy, progressive supranuclear palsy, corticobasal degeneration, and spinocerebellar ataxia.

CME Faculty

David Shprecher, DO Msci, FAAN

Banner Sun Health Research Institute

David Shprecher, DO, MSci, FAAN is Movement Disorders Director for Banner Research and Clinical Associate Professor for University of Arizona-Phoenix. Dr. Shprecher completed a doctor of osteopathic medicine degree at Lake Erie College of Osteopathic Medicine and a Neurology residency... Read More →

Sunday June 29, 2025 10:00am - 10:30am EDT
Woodrow Wilson B-D

CME General

10:45am EDT

Current and Emerging Therapies in Alzheimer’s and Other Dementias - 1 CME

Sunday June 29, 2025 10:45am - 11:45am EDT

Woodrow Wilson B-D

Recognition of dementia in its earliest stages is now critical with the advent of new treatments, but diagnosis can be challenging given the variable patient presentations and numerous contributing causes (eg, Alzheimer’s, Lewy body dementia, vascular trauma, etc.). This session discusses the diagnosis and treatment of dementia, including the use of diagnostic biomarker tests and efficacy/safety of medications targeting amyloid-beta.

CME Faculty

Richard S. Isaacson, MD

Institute for Neurodegenerative Diseases

Richard S. Isaacson, MD, is a preventive neurologist and clinician researcher in the field of Alzheimer’s prevention. He founded and directed the first Alzheimer’s Prevention Clinic (APC) in the U.S. in 2013 at Weill Cornell Medicine/NewYork-Presbyterian, where he also served... Read More →

Sunday June 29, 2025 10:45am - 11:45am EDT
Woodrow Wilson B-D

CME General

12:45pm EDT

Lunch Industry Innovation Theater – Non-CME Event Sponsored by Merz Therapeutics

Sunday June 29, 2025 12:45pm - 1:45pm EDT

Woodrow Wilson B-D

Sunday June 29, 2025 12:45pm - 1:45pm EDT
Woodrow Wilson B-D

Sponsored (Non-CME), Non-CME

4:30pm EDT

Diagnosing Alzheimer's and Overlapping Pathologies: Determining Candidates for Anti-amyloid Therapies - 1 CME

Sunday June 29, 2025 4:30pm - 5:30pm EDT

Woodrow Wilson B-D

Neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease dementia, and Lewy body dementia share pathological and clinical features. This session discusses the co-pathologies and the use of blood, skin, cerebrospinal fluid, and other biomarkers to aid in the differential diagnosis, and treatments to be considered including whether to split into individual pathology or clusters. Treatments to be considered include the targeting of amyloid beta for Alzheimer’s disease.

CME Faculty

Richard S. Isaacson, MD

Institute for Neurodegenerative Diseases

David Shprecher, DO Msci, FAAN

Banner Sun Health Research Institute

Yasar Torres-Yaghi, MD

ATMRD Course Director, MedStar Georgetown University Hospital

Yasar Torres Yaghi, MD is a board-certified neurologist at the MedStar Georgetown University Hospital in Washington, DC and Co-Director of the Lewy Body Dementia Clinic. He obtained his medical degree from George Washington University School of Medicine, and subsequently completed... Read More →

Sunday June 29, 2025 4:30pm - 5:30pm EDT
Woodrow Wilson B-D

CME General

6:45pm EDT

Grand Rounds – Non-CME Event Sponsored by Boston Scientific

Sunday June 29, 2025 6:45pm - 8:15pm EDT

Woodrow Wilson B-D

Sunday June 29, 2025 6:45pm - 8:15pm EDT
Woodrow Wilson B-D

Sponsored (Non-CME), Non-CME

9:00am EDT

Empathy in Action Breakfast: Multi-Sensory Experiential Hands-On Session – 1.5 CME

Monday June 30, 2025 9:00am - 10:45am EDT

Woodrow Wilson B-D

While healthcare providers seek to manage the significant motor and non-motor symptoms, having the opportunity to step into their patients' experiences may help them with patient communication, influence treatment approaches, and foster a deeper understanding of symptom burden and the need for personalized strategies. This multisensory, hands-on experience is designed to simulate various motor and nonmotor symptoms in Parkinson's disease and related disorders.

Monday June 30, 2025 9:00am - 10:45am EDT
Woodrow Wilson B-D

CME Experiential